Poolbeg Pharma PLC
POLB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £35,439 | £45 | £30 | £48 |
| - Cash | £7,824 | £12,171 | £16,193 | £20,949 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £27,615 | -£12,126 | -£16,163 | -£20,902 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | -£114 | -£26 | -£26 | -£18 |
| % Margin | – | – | – | – |
| EBITDA | -£5,997 | -£4,660 | -£4,751 | -£2,318 |
| % Margin | – | – | – | – |
| Net Income | -£5,790 | -£3,931 | -£4,686 | -£2,336 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.012 | -7.86 | -9.37 | -4.67 |
| % Growth | 99.9% | 16.1% | -100.6% | – |
| Operating Cash Flow | -£4,646 | -£3,847 | -£4,368 | -£2,146 |
| Capital Expenditures | -£129 | -£175 | -£597 | -£81 |
| Free Cash Flow | -£4,775 | -£4,022 | -£4,965 | -£2,227 |